Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
Open Access
- 18 May 2010
- journal article
- research article
- Published by Springer Nature in BMC Pediatrics
- Vol. 10 (1), 33
- https://doi.org/10.1186/1471-2431-10-33
Abstract
Among children, early mortality following highly active antiretroviral therapy (HAART) remains high. It is important to define correlates of mortality in order to improve outcome. HIV-1-infected children aged 18 months-12 years were followed up at Kenyatta National Hospital, Nairobi after initiating NNRTI-based HAART. Cofactors for mortality were determined using multivariate Cox regression models. Between August 2004 and November 2008, 149 children were initiated on HAART of whom 135 were followed for a total of 238 child-years (median 21 months) after HAART initiation. Baseline median CD4% was 6.8% and median HIV-1-RNA was 5.98-log10 copies/ml. Twenty children (13.4%) died at a median of 35 days post-HAART initiation. Mortality during the entire follow-up period was 8.4 deaths per 100 child-years (46 deaths/100 child-years in first 4 months and 1.0 deaths/100 child-years after 4 months post-HAART initiation). On univariate Cox regression, baseline hemoglobin (Hb) <9 g/dl, weight-for-height z-score (WHZ) < -2, and WHO clinical stage 4 were associated with increased risk of death (Hb <9 g/dl HR 3.00 [95% C.I. 1.21-7.39], p = 0.02, WHZ < -2 HR 3.41 [95% C.I. 1.28-9.08], p = 0.01, and WHO clinical stage 4, HR 3.08 [1.17-8.12], p = 0.02). On multivariate analysis Hb < 9 g/dl remained predictive of mortality after controlling for age, baseline CD4%, WHO clinical stage and weight-for-height z-score (HR 2.95 (95% C.I. 1.04-8.35) p = 0.04). High early mortality was observed in this cohort of Kenyan children receiving HAART, and low baseline hemoglobin was an independent risk factor for death.Keywords
This publication has 24 references indexed in Scilit:
- Cardiovascular disease and HIV infection: host, virus, or drugs?Current Opinion in Infectious Diseases, 2009
- Iron Deficiency in Young Children in Low-Income Countries and New Approaches for Its PreventionJournal of Nutrition, 2008
- Early Antiretroviral Therapy and Mortality among HIV-Infected InfantsNew England Journal of Medicine, 2008
- Excessive Early Mortality in the First Year of Treatment in HIV Type 1-Infected Patients Initiating Antiretroviral Therapy in Resource-Limited SettingsAIDS Research and Human Retroviruses, 2008
- Efficacy of Highly Active Antiretroviral Therapy in HIV-1–Infected Children in KenyaPediatrics, 2007
- Effector T lymphocytes in well-nourished and malnourished infected childrenClinical and Experimental Immunology, 2007
- Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimensAIDS, 2006
- Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'IvoireAIDS, 2004
- Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and IrelandBMJ, 2003
- Human Immunodeficiency Virus Infection, Anemia, and SurvivalClinical Infectious Diseases, 1999